Table 1 Patient demographics
Population | 111 |
|---|---|
Median age (range) | 64 (43-81) |
Gender | |
Male (%) | 65 (58.6) |
Female (%) | 46 (41.4) |
Histology | |
Adenocarcinoma (%) | 68 (61.3) |
Squamous cell carcinoma (%) | 25 (22.5) |
Small cell carcinoma (%) | 10 (9.0) |
Other (%) | 8 (7.2) |
Nr. of treatment lines | 155 |
Standard chemotherapy (SC) | 62 |
Targeted therapy (MTA)a | 93 |
Stage at diagnosis | |
I (%) | 20 (18.0) |
II (%) | 18 (16.2) |
III (%) | 35 (31.5) |
IV (%) | 33 (29.7) |
N/A (%) | 5 (4.5) |
Surgical status | |
Operated (%) | 51 (45.9) |
Not operated (%) | 60 (54.1) |
ECOG status | |
0 (%) | 65 (58.6) |
1 (%) | 29 (26.1) |
2 (%) | 2 (1.8) |
N/A (%) | 15 (13.5) |
Lines of therapies (LOT) | |
Patients who received 1 LOT (%) | 35 (32) |
Patients who received 2 LOTs (%) | 31 (28) |
Patients who received 3 or more LOTs (%) | 17 (15) |
Patients without LOT (%) | 28 (25) |
